So IDDP fans here is part of a press release about another IDDP projetc just off the news wire:
JDRF partners with Plureon to explore generating insulin-producing cells from adult stem cells
NEW YORK, February 4, 2008 – The Juvenile Diabetes Research Foundation (JDRF), the world’s largest charitable funder of type 1 diabetes research, announced today that it is partnering with Plureon Corporation, a biotechnology company based in Winston-Salem, N.C. that focuses on developing therapeutic applications of stem
Through its Industry Discovery and Development Partnership Program,
JDRF is providing $500,000 over two years of research funding aimed at
developing an insulin-producing beta cell therapy product for the treatment of
type 1 diabetes.
The project plans to use Plureon’s technology platform to isolate adult
stem cells from a type 1 diabetes patient and re-program them to generate fully
functional pancreatic beta-cells. The objective is to return the re-programmed
insulin-producing cells back into the patient in an autologous manner, i.e.,
without the need for immunosuppressive agents normally required for organ
transplantation – in this manner, the patient’s own transplanted cells will be
capable of glucose-dependent insulin secretion and the restoration of normal
blood sugar levels.